SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-061746
Filing Date
2024-05-17
Accepted
2024-05-17 16:38:06
Documents
1
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4050
  Complete submission text file 0000950170-24-061746.txt   5489
Mailing Address 3 SOMERSET DRIVE SOUTH GREAT NECK NY 11020
Business Address
PAPADOPOULOS STELIOS (Reporting) CIK: 0001202098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 24960489

Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)